Follow
Matthew J. Ellis
Matthew J. Ellis
Physician Scientist, Oncologist
Verified email at progendis.com
Title
Cited by
Cited by
Year
Comprehensive molecular portraits of human breast tumours
Cancer Genome Atlas Network
Nature 490 (7418), 61-70, 2012
10955*2012
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, J Matera, MC Miller, ...
New England Journal of Medicine 351 (8), 781-791, 2004
52672004
Supervised risk predictor of breast cancer based on intrinsic subtypes
JS Parker, M Mullins, MCU Cheang, S Leung, D Voduc, T Vickery, ...
Journal of clinical oncology 27 (8), 1160-1167, 2009
50542009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer
MCU Cheang, SK Chia, D Voduc, D Gao, S Leung, J Snider, M Watson, ...
JNCI: Journal of the National Cancer Institute 101 (10), 736-750, 2009
30672009
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National Cancer Institute 103 (22), 1656-1664, 2011
20132011
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 379 (2), 111-121, 2018
20032018
The molecular portraits of breast tumors are conserved across microarray platforms
Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ...
BMC genomics 7, 1-12, 2006
18632006
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
15262016
Prospective validation of a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 373 (21), 2005-2014, 2015
14972015
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1–and/or ErbB-2–positive, estrogen receptor–positive primary breast cancer: evidence from a …
MJ Ellis, A Coop, B Singh, L Mauriac, A Llombert-Cussac, F Jänicke, ...
Journal of Clinical Oncology 19 (18), 3808-3816, 2001
14572001
Proteogenomic characterization of human colon and rectal cancer
B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ...
Nature 513 (7518), 382-387, 2014
13862014
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli, DF Hayes, GT Budd, MJ Ellis, A Stopeck, JM Reuben, ...
Journal of Clinical Oncology 23 (7), 1420-1430, 2005
13582005
Genome remodelling in a basal-like breast cancer metastasis and xenograft
LI Ding, MJ Ellis, S Li, DE Larson, K Chen, JW Wallis, CC Harris, ...
Nature 464 (7291), 999-1005, 2010
13492010
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
DF Hayes, M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, MC Miller, ...
Clinical Cancer Research 12 (14), 4218-4224, 2006
12122006
Whole-genome analysis informs breast cancer response to aromatase inhibition
MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ...
Nature 486 (7403), 353-360, 2012
11942012
CDK4/6 inhibition triggers anti-tumour immunity
S Goel, MJ DeCristo, AC Watt, H BrinJones, J Sceneay, BB Li, N Khan, ...
Nature 548 (7668), 471-475, 2017
11582017
Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer
GT Budd, M Cristofanilli, MJ Ellis, A Stopeck, E Borden, MC Miller, ...
Clinical Cancer Research 12 (21), 6403-6409, 2006
9612006
Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study
W Eiermann, S Paepke, J Appfelstaedt, A Llombart-Cussac, J Eremin, ...
Annals of Oncology 12 (11), 1527-1532, 2001
9262001
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
8832016
Activating HER2 mutations in HER2 gene amplification negative breast cancer
R Bose, SM Kavuri, AC Searleman, W Shen, D Shen, DC Koboldt, ...
Cancer discovery 3 (2), 224-237, 2013
8812013
The system can't perform the operation now. Try again later.
Articles 1–20